Featured Research

from universities, journals, and other organizations

Stem cell researchers call for research ethics consortium

Date:
September 21, 2010
Source:
University of South Florida (USF Health)
Summary:
Two stem cell researchers propose creating an independent national "Stem Cell Research Ethics Consortium" to provide better guidance on stem cell issues for regulatory agencies, lawmakers and policy-makers.

Two University of South Florida stem cell researchers propose creating an independent national "Stem Cell Research Ethics Consortium" to provide better guidance on stem cell issues for regulatory agencies, law makers and policy makers.

Their recommendation is timely, and came before the recent ruling by a U.S. judge that halted expansion of federal funding for embryonic stem cell research. The ruling reversed the attempt to overturn the standing moratorium on federal funding for such research and subsequent appeals.

USF neuroscientists Dr. Paul Sanberg and Dr. Cesario Borlongan are pioneers in the development of umbilical cord blood and adult stem cells for use as therapies for stroke, neurodegenerative diseases and cardiovascular disease. Their commentary appears in the journal Technology and Innovation -- The Proceedings of the National Academy of Inventors.

"Two decades of cell-based research has been accompanied by poor management of public discussion regarding ethics," said Dr. Sanberg, executive director of the USF Center of Excellence for Aging and Brain Repair. "Stem cell science has contributed to misperceptions within the public and the research communities, and those misperceptions have hindered the progress of scientific innovation. As a result, clinical application of potentially life-saving treatments to critically ill patients has been delayed and, in some cases, impeded."

According to co-author Dr. Borlongan, vice chairman for research in the USF Department of Neurosurgery and Brain Repair, discussion of the emerging technologies for stem cell-based therapies has often been driven by conflict rather than fact.

"Because of the lack of effective communication between scientists and the public, conflicts have largely played out in the media," said Dr. Borlongan. "In some respects, the failure of the scientific community to effectively address controversy in stem cell research has helped create today's heated, yet poorly informed, debate. We need a Stem Cell Ethics Research Consortium, independent of governmental, political, religious, and scientific organizations, comprised of diverse interests, to sort out the ethical, legal and social issues, and then determine an appropriate mechanism for public discourse and policy making."

The proposed Consortium, conceived as an independent, "honest broker," would be useful in shaping policy on all emerging technologies, not just stem cell science, said Drs. Sanberg and Borlongan. They advocate using members of diverse focus groups to identify issues and discuss them with various communities and return with recommendations. Accordingly, the Consortium's first task would be to establish baseline data about the public view on stem cell science. Collected data should be analyzed to assess the range of options, beliefs and concerns of focus group members' constituents.

The USF researchers envision the Consortium playing a proactive rather than a reactive role and contributing to a deliberate assessment of public opinion about stem cell research aimed at revising or creating meaningful oversight.

"An informed Consortium can then provide ethically-based regulatory options to NIH for use in its ongoing development of guidelines for all stem cell research, not just for embryonic stem cells," said Dr. Sanberg. "The members of the Consortium, enlisted from a wide variety of stakeholders, could evaluate how novel ethical issues in emerging technologies are addressed under current oversight and regulatory structures and where there may be gaps and need for revision or new policy approaches."

The Consortium, suggests Dr. Sanberg, could also be charged with determining the best uses of public funds in investigations of not only stem cells, but other emerging technologies, such as energy, nanotechnology and personalized medicine.

"Bringing together all stakeholders -- including the legal, scientific, religious and the public sectors -- should allow a much more educated and logical approach in handling the public disbursement of funds for stem cell research," concluded Drs. Sanberg and Borlongan.


Story Source:

The above story is based on materials provided by University of South Florida (USF Health). Note: Materials may be edited for content and length.


Journal Reference:

  1. Cesar V. Borlongan, Camille McWhirter, Caroline Fultz-Carver, Kevin T. FitzGerald, and Paul R. Sanberg. The Case for an Ethics Research Consortium for Emerging Technologies: Public Perception of Stem Cell Research and Development. Technology and Innovation, 2010; 12 (1): 21-28 DOI: 10.3727/194982410X12741230805263

Cite This Page:

University of South Florida (USF Health). "Stem cell researchers call for research ethics consortium." ScienceDaily. ScienceDaily, 21 September 2010. <www.sciencedaily.com/releases/2010/09/100921101513.htm>.
University of South Florida (USF Health). (2010, September 21). Stem cell researchers call for research ethics consortium. ScienceDaily. Retrieved August 2, 2014 from www.sciencedaily.com/releases/2010/09/100921101513.htm
University of South Florida (USF Health). "Stem cell researchers call for research ethics consortium." ScienceDaily. www.sciencedaily.com/releases/2010/09/100921101513.htm (accessed August 2, 2014).

Share This




More Health & Medicine News

Saturday, August 2, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Texas Quintuplets Head Home

Texas Quintuplets Head Home

Reuters - US Online Video (Aug. 1, 2014) After four months in the hospital, the first quintuplets to be born at Baylor University Medical Center head home. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Patient Coming to U.S. for Treatment

Ebola Patient Coming to U.S. for Treatment

Reuters - US Online Video (Aug. 1, 2014) A U.S. aid worker infected with Ebola while working in West Africa will be treated in a high security ward at Emory University in Atlanta. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Ebola Vaccine Might Be Coming, But Where's It Been?

Ebola Vaccine Might Be Coming, But Where's It Been?

Newsy (Aug. 1, 2014) Health officials are working to fast-track a vaccine — the West-African Ebola outbreak has killed more than 700. But why didn't we already have one? Video provided by Newsy
Powered by NewsLook.com
Study Links Certain Birth Control Pills To Breast Cancer

Study Links Certain Birth Control Pills To Breast Cancer

Newsy (Aug. 1, 2014) Previous studies have made the link between birth control and breast cancer, but the latest makes the link to high-estrogen oral contraceptives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins